Refractory restless legs syndrome likely caused by olanzapine

Journal of Clinical Sleep Medicine

Volumn 5, Issue 1, 2009, Pages 68-69

  Khalid, Imran ^a   Rana, Lopa ^a   Khalid, Tabindeh J ^a   Roehrs, Timothy ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Olanzapine; Restless legs syndrome

Indexed keywords

ARIPIPRAZOLE; CLONAZEPAM; DEXTROPROPOXYPHENE; OLANZAPINE; PAROXETINE; ROPINIROLE;

ADD ON THERAPY; ADULT; AKATHISIA; ARTICLE; BEDTIME DOSAGE; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; RATING SCALE; RESTLESS LEGS SYNDROME; SCORING SYSTEM; TREATMENT RESPONSE;

EID: 61449180283     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.27396     Document Type: Article

References (9)

1. Paulus W, Dowling P, Rijsman R, Stiasny-Kolster K, Trenkwalder C, de Weerd A. Pathophysiological concepts of restless legs syndrome. Mov Disord 2007;22:1451-6.
2. Kessler RM. Aripiprazole: what is the role of dopamine D(2) receptor partial agonism? Am J Psychiatry 2007;164:1310-2.
3. Kang SG, Lee HJ, Kim L. Restless legs syndrome and periodic limb movements during sleep probably associated with olanzapine: case series and discussion. J Psychopharmacol. 2008 Jun 18 [Epub].
4. Kryger MH, Roth T, Dement WC. Principles and practice of sleep medicine, 4th ed. Philadelphia: Elsevier Saunders, 2005:844-6.
5. Kraus T, Schuld A, Pollmächer T. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol 1999;19:478-9.
6. Ruaño G, Goethe JW, Caley C, et al. Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients. Mol Psychiatry 2007;12:474-82.
7. Wang JS, Taylor R, Ruan Y, et al. Olanzapine penetration into brain is greater in transgenic Abcb1a P-glycoprotein-deficient mice than FVB1 (wild-type) animals. Neuropsychopharmacology 2004;29:551-7.
8. Paulus W, Schomburg ED. Dopamine and the spinal cord in rest-less legs syndrome: does spinal cord physiology reveal a basis for augmentation? Sleep Med Rev 2006;10:185-96.
9. Rooney KF, Sewell RD. Evaluation of selective actions of dopamine D-1 and D-2 receptor agonists and antagonists on opioid antinociception. Eur J Pharmacol 1989;168:329-36.